Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Current Leases (2020 - 2025)

Historic Current Leases for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • Tango Therapeutics' Current Leases rose 834.79% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 834.79%. This contributed to the annual value of $2.5 million for FY2024, which is 1786.74% up from last year.
  • Tango Therapeutics' Current Leases amounted to $3.1 million in Q3 2025, which was up 834.79% from $2.5 million recorded in Q2 2025.
  • Tango Therapeutics' Current Leases' 5-year high stood at $3.1 million during Q3 2025, with a 5-year trough of $629000.0 in Q2 2022.
  • Moreover, its 5-year median value for Current Leases was $2.1 million (2024), whereas its average is $2.0 million.
  • Its Current Leases has fluctuated over the past 5 years, first tumbled by 2847.99% in 2022, then soared by 18728.14% in 2023.
  • Quarter analysis of 5 years shows Tango Therapeutics' Current Leases stood at $1.5 million in 2021, then grew by 17.76% to $1.8 million in 2022, then grew by 17.63% to $2.1 million in 2023, then rose by 17.87% to $2.5 million in 2024, then rose by 26.41% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.5 million for Q2 2025, and $2.8 million during Q1 2025.